Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Xylitol vs Saline Nasal Irrigations in CF-CRS

NCT: NCT05531630 · ENROLLING_BY_INVITATION

NCT IDNCT05531630
StatusENROLLING_BY_INVITATION
Start Date2022-12-01
Completion2026-12-30

Brief Summary

Cystic fibrosis (CF) is the most common genetic disorder in Belgium, affecting 1 in 2850 children. A defect in the CFTR channel results in increased viscosity of extracellular secretions and decreased mucociliary clearance in the airways. As a result of this mechanism, chronic rhinosinusitis (CRS) occurs in nearly 100% of CF patients. CRS can lead to pronounced sinonasal complaints and can have a negative impact on the quality of life. In addition, several studies have shown that poor upper airway control has a negative impact on the lower airways. Unfortunately, treatment options are limited. Our previous study has shown that only 21% of patients have well-controlled CRS. The aim of this single-center, randomized cross-over study is to compare the effect of nasal rinses with (XNI) and without (SNI) Xylitol in the treatment of CF-CRS. Xylitol is a sugar alcohol that is already used as an antibiofilm agent,eg in the prevention of caries. Previous pilot studies have already shown a beneficial effect of XNI in the treatment of non-CF CRS.

Frequently Asked Questions

What is Xylitol vs Saline Nasal Irrigations in CF-CRS?

Xylitol vs Saline Nasal Irrigations in CF-CRS is a clinical trial registered under NCT05531630. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT05531630?

The current status of NCT05531630 (Xylitol vs Saline Nasal Irrigations in CF-CRS) is: ENROLLING_BY_INVITATION.

When did Xylitol vs Saline Nasal Irrigations in CF-CRS start?

Xylitol vs Saline Nasal Irrigations in CF-CRS started on 2022-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.